BRKR Bruker Corporation

Bruker Daltonics today announces that it will hold a press conference at the American Society for Mass Spectrometry's 53rd Annual Conference in San Antonio, Texas to announce new mass-spectrometry based products for its pharmaceutical, molecular diagnostics, clinical proteomics and other life-science research customers. Bruker Daltonics' ASMS press conference will take place on Tuesday, June 7th, from 1:00 p.m. to 2:00 p.m. in Media Room 206A at the Henry B. Gonzalez Convention Center. Editors, journalists and institutional investors who plan to attend the press conference are asked to RSVP to Michael.Willett@bruker-biosciences.com. For further information on the ASMS conference, please see www.asms.org. ABOUT BRUKER BIOSCIENCES (NASDAQ: BRKR) Bruker BioSciences Corporation, headquartered in Billerica, Massachusetts, is the publicly traded parent company of Bruker AXS Inc. and Bruker Daltonics Inc. Bruker AXS is a leading developer and provider of life science and advanced materials research tools based on X-ray technology. Bruker Daltonics is a leading developer and provider of innovative life science tools based on mass spectrometry. For more information, please visit www.bruker-biosciences.com